The Claim
Intravenous lysine infusion in healthy children is associated with increased plasma arginine concentrations and unchanged plasma urea concentrations, suggesting inhibited arginase activity without a net reduction in urea production.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When healthy children receive lysine through an IV, their blood arginine levels rise and urea levels stay the same, indicating that the enzyme arginase is less active but urea production does not decrease overall.
See the scientific wording
Intravenous lysine infusion in healthy children is associated with increased plasma arginine and unchanged plasma urea, suggesting inhibited arginase activity without a net reduction in urea production.
Lysine blocks two key steps in the liver's ammonia cleanup system: it stops arginine from being turned into urea, causing arginine to build up in the blood, and it also blocks ornithine from entering the energy-producing part of the liver cell. This causes ammonia and other chemicals to pile up and get redirected into other waste pathways, but the liver still makes the same amount of urea by using leftover materials from other reactions.
What the research says
1 studyStudy: Inhibitory effect of intravenous lysine infusion on urea cycle metabolism
When kids got a special IV drip of lysine, their blood arginine went up but their urea stayed the same — meaning one part of their body’s ammonia cleanup slowed down, but the rest of the system kept working to make the same amount of urea.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.